Roivant Sciences Director Keith S. Manchester sold over $56.4 million in company stock according to filings reported on July 1, 2026.
The transactions occurred between June 26 and June 30, 2026, at prices ranging from $33.92 to $35.45 per share.
The sales involved both direct holdings and indirect shares held through QVT Financial Investment Cayman Ltd.
Manchester continues to hold a significant ownership position in the company both directly and indirectly.